Showing results (971-980 of 3,965) with videos related to

Sort By:
Pageof 397
Translational Cancer Research|July 14, 2026
A stromal-derived five-gene signature predicts gastric cancer recurrence through integrated bioinformatics and single-cell analysisYi Wang, Rui Mao
Translational Cancer Research|August 31, 2018
Circular RNAs and competing endogenous RNA (ceRNA) networksApratim Mitra, Karl Pfeifer, Ki-Sun Park
Translational Cancer Research|August 13, 2026
Hepatotoxicity of immune checkpoint inhibitor plus targeted therapy versus tyrosine kinase inhibitor monotherapy in unresectable hepatocellular carcinoma: a systematic review and meta-analysisShuangyue Wang, Yajuan He, Yingfei Wei, et al.
Translational Cancer Research|August 13, 2026
Garcinoic acid promotes ferroptosis-associated growth inhibition in esophageal squamous cell carcinoma through an MDM2-associated mechanismLi-Ying Sun, Peng Huang, Yan-Hua Su
Translational Cancer Research|August 13, 2026
In vitro characterization of a novel anti-GD2/ROR1 bispecific antibody exhibiting tumor cell killing efficacy in neuroblastoma cross-cancer activity in ROR1-positive triple-negative breast cancerTian Lin, Xinghe Chen, He Huang, et al.
Translational Cancer Research|August 13, 2026
Elevated TMC8 expression correlates with CD8+ T cell infiltration and favorable survival in oral squamous cell carcinomaBingyan Zhu, Yuling Chen, Tao Zhou, et al.
Translational Cancer Research|August 13, 2026
Efficacy of nab-paclitaxel combined with immune checkpoint inhibitors in solid tumors: a systematic review and meta-analysis of randomized controlled trialsXiao Li, Yaqiong Song, Jianhua Li
Translational Cancer Research|August 13, 2026
Clinicopathological characteristics and prognosis of pulmonary spindle cell carcinoma: a population-based retrospective study using SEER dataLinwei Zhuang, Jianli Gao, Yi Zhang, et al.
Translational Cancer Research|August 13, 2026
TRIM32 drives head and neck squamous cell carcinoma progression via TP53 suppression and lysosomal/autophagy dysregulationLangxiong Chen, Yuyang Zhang, Huaying Liao, et al.
Translational Cancer Research|August 13, 2026
Matching-adjusted indirect comparison between asciminib and flumatinib as first-line treatment for chronic myeloid leukemia in ChinaYing Wang, Yan Hui, Li Zhang, et al.
Pageof 397